6月30日，真健康医疗-B盘中上涨165.45%，报335.0港元/股，成交额1.7亿港元。该股今日正式于港交所主板挂牌交易，发售价为每股126.20港元。
消息面上，公司本次全球发售合计356.47万股H股，香港公开发售获1790.4倍超额认购，一手中签率仅2.00%，市场打新热度极高；国际发售认购倍数为2.2倍，承配人合计107名。此前暗盘交易阶段，该股已录得超143%涨幅，反映市场对其估值预期远高于发售价。公司为国内经皮穿刺手术及消融手术机器人研发企业，被市场称为"穿刺手术机器人第一股"，所得款项净额约3.84亿港元，主要用于核心手术机器人产品的研发及商业化。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.